HB4783 • 2025

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor: VanDeaver
Last action: 2025-06-20
Official status: 06/20/2025 E Effective on 9/1/25
Effective date: 2025-06-20

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

What This Bill Does

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2025-06-20 Texas Legislature Online
Signed by the Governor
2025-06-20 Texas Legislature Online
Effective on 9/1/25
2025-05-26 Texas Legislature Online
Sent to the Governor
2025-05-25 Texas Legislature Online
Signed in the House
2025-05-25 Texas Legislature Online
Signed in the Senate
2025-05-24 Texas Legislature Online
Reported enrolled
2025-05-23 Texas Legislature Online
House concurs in Senate amendment(s)
2025-05-23 Texas Legislature Online
Record vote. RV#3438
2025-05-23 Texas Legislature Online
Statement(s) of vote recorded in Journal
2025-05-23 Texas Legislature Online
Text of Senate Amendment(s)
2025-05-23 Texas Legislature Online
House concurs in Senate amendment(s)-reported
2025-05-21 Texas Legislature Online
Senate passage as amended reported
2025-05-21 Texas Legislature Online
Senate Amendments distributed
2025-05-21 Texas Legislature Online
Senate Amendments Analysis distributed
2025-05-20 Texas Legislature Online
Co-sponsor authorized
2025-05-20 Texas Legislature Online
Placed on intent calendar
2025-05-20 Texas Legislature Online
Rules suspended-Regular order of business
2025-05-20 Texas Legislature Online
Vote recorded in Journal
2025-05-20 Texas Legislature Online
Read 2nd time & passed to 3rd reading
2025-05-20 Texas Legislature Online
Vote recorded in Journal
2025-05-20 Texas Legislature Online
Three day rule suspended
2025-05-20 Texas Legislature Online
Record vote
2025-05-20 Texas Legislature Online
Read 3rd time
2025-05-20 Texas Legislature Online
Passed
2025-05-20 Texas Legislature Online
Record vote
2025-05-19 Texas Legislature Online
Reported favorably as substituted
2025-05-19 Texas Legislature Online
Recommended for local & uncontested calendar
2025-05-19 Texas Legislature Online
Committee report printed and distributed
2025-05-14 Texas Legislature Online
Considered in public hearing
2025-05-14 Texas Legislature Online
Vote taken in committee
2025-05-13 Texas Legislature Online
Scheduled for public hearing on . . .
2025-05-13 Texas Legislature Online
Considered in public hearing
2025-05-13 Texas Legislature Online
Testimony taken in committee
2025-05-13 Texas Legislature Online
Left pending in committee
2025-05-07 Texas Legislature Online
Read first time
2025-05-07 Texas Legislature Online
Referred to Health & Human Services
2025-05-06 Texas Legislature Online
Read 3rd time
2025-05-06 Texas Legislature Online
Passed
2025-05-06 Texas Legislature Online
Record vote. RV#1429
2025-05-06 Texas Legislature Online
Statement(s) of vote recorded in Journal
2025-05-06 Texas Legislature Online
Reported engrossed
2025-05-06 Texas Legislature Online
Received from the House
2025-05-05 Texas Legislature Online
Read 2nd time
2025-05-05 Texas Legislature Online
Passed to engrossment
2025-05-02 Texas Legislature Online
Placed on General State Calendar
2025-04-30 Texas Legislature Online
Considered in Calendars
2025-04-25 Texas Legislature Online
Committee report sent to Calendars
2025-04-23 Texas Legislature Online
Comte report filed with Committee Coordinator
2025-04-23 Texas Legislature Online
Committee report distributed
2025-04-17 Texas Legislature Online
Considered in formal meeting
2025-04-17 Texas Legislature Online
Reported favorably w/o amendment(s)
2025-04-14 Texas Legislature Online
Scheduled for public hearing on . . .
2025-04-14 Texas Legislature Online
Considered in public hearing
2025-04-14 Texas Legislature Online
Testimony taken/registration(s) recorded in committee
2025-04-14 Texas Legislature Online
Left pending in committee
2025-04-03 Texas Legislature Online
Read first time
2025-04-03 Texas Legislature Online
Referred to Public Health
2025-03-13 Texas Legislature Online
Filed

Official Summary Text

Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.

Current Bill Text

Read the full stored bill text

89(R) HB 4783 - Enrolled version - Bill Text

H.B. No. 4783

AN ACT

relating to a report on governmental opioid antagonist programs to

reverse and prevent opioid overdoses.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Subchapter B, Chapter 461A, Health and Safety

Code, is amended by adding Section 461A.060 to read as follows:

Sec.

461A.060.

BIENNIAL REPORT ON OPIOID ANTAGONIST

PROGRAMS FOR OPIOID OVERDOSE REVERSAL AND PREVENTION.

(a)

In this

section, "opioid antagonist" has the meaning assigned by Section

483.101.

(b)

Not later than October 1 of each even-numbered year, the

commission shall:

(1)

prepare a report evaluating the distribution of

opioid antagonists in this state to reverse and prevent opioid

overdoses; and

(2)

submit the report to the governor, the lieutenant

governor, and the speaker of the house of representatives.

(c) The report described by Subsection (b) must:

(1)

include a needs assessment for the opioid

antagonist programs established by state agencies and institutions

of higher education;

(2)

establish a statewide saturation goal for opioid

antagonists and include:

(A)

a description of the data sources and

methodology used to estimate insufficiencies in the current supply

of opioid antagonists; and

(B)

a communications plan to address opioid

overdoses in areas of this state at higher risk for increased

numbers of overdoses;

(3)

include a description of all state and federal

money appropriated to governmental opioid antagonist programs;

(4)

establish opioid antagonist distribution

strategies for this state;

(5)

list and describe all available state and

federally funded purchase and distribution programs for opioid

antagonists; and

(6)

recommend improvements for addressing opioid

overdoses among high-risk populations, including school-aged

children, pregnant and postpartum women, and individuals residing

in rural areas of this state.

(d)

In preparing the report under this section, the

commission shall coordinate and consult with each state agency and

institution of higher education that receives funding or other

resources for the distribution of opioid antagonists.

SECTION 2. This Act takes effect September 1, 2025.

______________________________

______________________________

President of the Senate

Speaker of the House

I certify that H.B. No. 4783 was passed by the House on May 6,

2025, by the following vote: Yeas 137, Nays 10, 1 present, not

voting; and that the House concurred in Senate amendments to H.B.

No. 4783 on May 23, 2025, by the following vote: Yeas 112, Nays 24,

1 present, not voting.

______________________________

Chief Clerk of the House

I certify that H.B. No. 4783 was passed by the Senate, with

amendments, on May 20, 2025, by the following vote: Yeas 30, Nays

1.

______________________________

Secretary of the Senate

APPROVED: __________________

Date

__________________

Governor